Siemens Aktiengesellschaft (SIE)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 255.70 |
|---|---|
| 52-week range | 198.00 – 291.70 |
| Return, 1 month / 3 months | −6.6% / −5.7% |
| Return, 1 year / 3 years | +7.9% / +116.2% |
| Trend | Below its 200-day average |
| RSI (14) | 37 |
| Volatility (1 year) | 33.0% |
| Worst drawdown (1 year) | -20.5% |
| Average daily value traded | 269.28M EUR |
| Dividend yield | 2.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Siemens Aktiengesellschaft is a German industrial technology company based in Munich. It supplies factory automation and digitalisation systems to manufacturers, building and energy infrastructure equipment and services to utilities and property operators, and rail vehicles and signalling through its mobility business. Its healthcare arm, Siemens Healthineers, makes medical imaging and diagnostic equipment for hospitals and clinics. The company serves industrial, infrastructure and healthcare customers around the world.
Siemens Aktiengesellschaft trades under the code SIE on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Siemens Aktiengesellschaft (SIE) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 255.70 on 22 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 150 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.9% and over the last three months it fell 5.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -1.1% | ||
| From 52-week high | -11.8% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -5.7% | ||
| 6-month return | 5.8% | ||
| 12-month return, skipping the last month | 15.6% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.5% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 269.28M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 46 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.1% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −5.5% |
|---|---|
| 1 month | −6.6% |
| 3 months | −5.7% |
| 6 months | +5.8% |
| 1 year | +7.9% |
| 3 years | +116.2% |
| 5 years | +108.5% |
Signals
| 50-day / 200-day average | 273.28 / 258.58 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.19 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Feb 2026 | EUR 5.3500 |
| 14 Feb 2025 | EUR 5.2000 |
| 9 Feb 2024 | EUR 4.7000 |
| 10 Feb 2023 | EUR 4.2500 |
| 11 Feb 2022 | EUR 4.0000 |
| 4 Feb 2021 | EUR 3.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.